ARCHIVES

ASCO: Anastrozole Adds Treatment Option, But Tamoxifen Remains Standard

This article is from The Cancer Letter archive.

Vol. 28 No. 33 | September 13, 2002

Download PDF Visit The Full Archive

Related Articles

DeMets Receives Lectureship On Epidemiology From NIH.

May 4, 2001

NCI Supports New Cervical Cancer Screening Guideline

January 31, 2003

In Brief: white House Names Phillip Sharp To NCAB; Shine Re-appointed As IOM President

September 27, 1996

Study Finds 4-20% Of Those With HTLV-3 Develop AIDs Within 32 Months Or Less

August 2, 1985

Dear ASCO Member Letter From Klausner Attempts To Rescue Flagging BMT Trial.

June 2, 2000

DCT Board Ok’s PA, BRM Contract Concepts

October 30, 1992